Guenther, L. et al. 2020. Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial. Acta Dermato-Venereologica. 100, 1 (Jan. 2020), 1–9. DOI:https://doi.org/10.2340/00015555-3353.